Tag: EU
For a wide spectrum of patients with CKD and type 2 diabetes, Kerendia was given an enhanced indication in the EU.
The phase III FIGARO-DKD study’s findings on cardiovascular (CV) outcomes received approval from the European Commission for inclusion…
